|
February
3rd 2003. The February report
highlights the JP Morgan Health Care Conference and is the leading
conference that provides an outlook on the biotechnology sector.
We will address key issues of what an investor should consider
when investing in biotechnology stocks. More importantly, you will
learn about what will be the dynamics influencing the development
of new medicines.
Among the
companies highlighted in this issue are: Forest Laboratories
(AMEX: FRX),
Intermune (NASDAQ: ITMN),
and Dendreon (NASDAQ: DNDN),
to name a few.
To learn more
about BioTech Stock Report, visit http://www.biostockreport.com
.
BioTech Stock
Report is published monthly. It has set the standard for
independent analysis of the biotechnology sector since 1997, as
the leader of independent research regarding biotechnology
companies specializing in the development of innovative therapies
for diseases. Hardcopy or electronic delivery of the BioTech Stock
Report are available.
Subscription
Rates: 6 months trial
$150, 1 year $299, 2 years $495.
Outside the
US/Canada add $36 per year for hardcopy airmail.
Contact:
Wong’s BioTech Stock Report, P.O. Box 7274, Beaverton, OR
97007; 503-649-1355; fax: 503-649-4490; Email: info@biostockreport.com
Web Site: www.biostockreport.com
The contents of
this publication are based on sources that are believed reliable,
but accuracy cannot be guaranteed. This is not an offer to buy or
sell securities. BioTech Stock Report is not a registered
securities dealer. The information and opinions are for
informational purposes only, and are not intended as investment
advice. The companies discussed may carry significant investment
risk. Readers should review information thoroughly with a
registered investment advisor or stockbroker. The publisher and
its directors or employees may have positions in and make
purchases or sales of securities discussed in this publication.
Contact:
Nadine Wong
Company:
BioTech Stock Report
Voice:
503-649-1355
Fax:
503-649-4490
|
| To
subscribe to the Biotech Stock Report - click
here!
DISCLAIMER
The above information transmitted via BioPortfolio has been provided by the original publishers
Nadine Wong of Wong & Wong Inc the publishers of the Biotech
Stock Report and http://www.biostockreport.com
("BSN") a financial information, news, and
software service focusing on event-driven biotechnology and
pharmaceutical research. The Service is provided by Nadine
Wong of Wong & Wong Inc ("NWWW").
It is not guaranteed as to completeness or accuracy by BioPortfolio, the
BSN publishers, or any person. Such Information is neither an offer to sell nor a solicitation to buy the securities of any company. Opinions expressed are subject to change without notice. The Information and views provided by
BSN are prepared by BSN employees and in no way reflect the views or efforts of BioPortfolio Limited., any of BioPortfolio's employees or officers. BioPortfolio, and BioPortfolio's employees and officers, as well as
BSN’s employees and officers, in no way accept responsibility for any of the
BSN content published on
www.bioportfolio.com/.
While all reasonable care has been taken to ensure that the Information contained herein is presented in good faith, and is not untrue or misleading at the time of publication, BioPortfolio, and
BSN make no representation as to its accuracy or completeness and it should not be relied upon as such. The Information is supplied on the condition that the reader or any other person receiving the Information will make his or her own determination as to its suitability for any purpose prior to any use of the Information. From time to time, BioPortfolio and any officers or employees of BioPortfolio, as well as
BSN, and any officers or employees of BSN, may, to the extent permitted by law, have a position or otherwise be interested in any transactions, in any investments (including derivatives) directly or indirectly the subject of this report. Also BioPortfolio and
BSN may, from time to time solicit business from any company mentioned in this report. This report is provided solely for the information of viewers of BioPortfolio and/or viewers and subscribers of
BSN and BioPortfolio information services, who are expected to make their own investment decisions without reliance on this report. Neither BioPortfolio nor any officer or employee of BioPortfolio, nor
BSN, or any officer or employee of BSN, accepts any liability whatsoever for any direct, indirect, special or consequential damages or loss arising from any use of this report or their contents. This report may not be reproduced, distributed or published by any recipient for any purpose without the prior express consent of the publishers. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent, trademark or copyright of BioPortfolio,
BSN or any third party.
The value of the investment(s) to which this report relates and their income
yield(s) may go up or down. The investment(s) referred to in this report may not be suitable for private investors: if you are in any doubt you should seek advice from your investment advisor. Changes in rates of currency exchange may have an adverse effect on the value, price or income of investments. Statements as to past performance of any investment are not a guide to future performance. The levels and bases of taxation can change, and if you are in doubt you should seek independent professional advice. In some cases it may be difficult for you to sell or realize your investment or to obtain reliable information about its value or the extent of the risks to which you are exposed.
THIS INFORMATION IS PROVIDED "AS IS" AND NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESS OR IMPLIED OF ACCURACY, MERCHANTIBILITY FITNESS FOR A PARTICULAR PURPOSE OR OF ANY OTHER NATURE ARE MADE WITH RESPECT TO THIS INFORMATION OR TO ANY EXPRESSED VIEWS PRESENTED IN THIS INFORMATION. |
